Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)
NCT03250195 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2022-11-04
Summary
The aim of the study is to examine the value of the new MRI techniques (spectroscopy and DWI), and FDG-PET in prognostication of male infertility.
Conditions
- Fertility Disorders
Interventions
- DIAGNOSTIC_TEST
-
PET/MRI
PET/MRI scan
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Louise Risør · Rigshospitalet, Denmark
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-08-07
- Primary Completion
- 2021-08-07
- Completion
- 2021-08-07
Countries
- Denmark
Study Locations
More Related Trials
-
Molecular Pituitary Imaging Using 18F-FET PET
NCT06584123 ·Status: RECRUITING ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
Positron Emission Tomography in Detecting Testicle Cancer
NCT00045045 ·Status: COMPLETED ·Phase: NA
-
18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer
NCT04809584 ·Status: APPROVED_FOR_MARKETING
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
Early Versus Late FDG-PET/CT in Bladder Cancer
NCT03065725 ·Status: COMPLETED
-
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
NCT05826158 ·Status: RECRUITING ·Phase: NA
-
18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
NCT02969564 ·Status: COMPLETED
-
Feasibility Assessment of Next-generation PET Technology and Procedures
NCT03387618 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PSMA PET and MRI in Gynecological Cancers
NCT03302156 ·Status: TERMINATED ·Phase: PHASE2
-
18F-DCFPyL PET-CT Scan and Prostate Cancer
NCT03852654 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA)
NCT03714763 ·Status: UNKNOWN ·Phase: NA
-
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
NCT04838626 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring
NCT01752231 ·Status: TERMINATED
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
NCT05709171 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients
NCT03011749 ·Status: TERMINATED ·Phase: NA
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
[F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
NCT00556153 ·Status: WITHDRAWN
-
Single Breath Hold Abdominal MRI
NCT02434471 ·Status: COMPLETED ·Phase: NA
-
PET/MR Characterization of Renal Cell Carcinomas
NCT04271254 ·Status: TERMINATED ·Phase: NA
-
Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors
NCT03905538 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
NCT05396118 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2